Recently, in non-small cell lung cancer cells, the AXL inhibitor BGB324 (Bencentinib) has been shown to induce DNA damage and replication stress indicated by ATR/CHK1 phosphorylation [39]. The gene discussed is CHEK1; the disease is non-small cell lung carcinoma.